News

Hygieia Inc. today announced receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for core patent claims broadly covering the company's Diabetes Insulin Guidance System ...
Hygieia announced Tuesday it signed an agreement with Dearborn-based Metro Detroit Endocrinology Center to distribute its autonomous insulin therapy to the practice's patients suffering with Type ...
Digital health and insulin management company Hygieia is adding Endocrine Associates of West Village in New York City and Physicians East in Greenville, N.C., as partners.
The Ann Arbor medical device firm Hygieia has secured $1.5 million in investment capital from Oakwood Medical Investors, a physician-managed venture fund in St. Louis, Mo.
Two new Category III CPT codes are approved for autonomous insulin dose titration, which can be used for Hygieia’s d-Nav® Technology.
Press Release Hygieia, a digital therapeutics company for insulin therapy, is extending its Series B funding round to $22 million with a lead investment from Firstime Ventures and additional ...
Ann Arbor, Michigan-based medical device company, Hygieia has teamed up with Blue Cross Blue Shield of Michigan in order to launch a 12-month study with its d-Nav service created to help about ...
The numbers are alarming. People are losing their eyesight, their limbs, and their lives to Type 2 Diabetes.
The goddess of health, Hygieia, must be thrilled to have her head—in this case, the head of a statue—pulled from the dusty ruins of an ancient amphitheater after 2,100 years.
Hygieia, a provider of digital therapeutics for insulin management, has added Endocrine Associates of West Village P.C. in Manhattan and Long Island C ...
LIVONIA, Mich., January 10, 2023--Hygieia expands to Arizona, as another practice joins d-Nav® Insulin Management Clinical Partnership Program.
LIVONIA, Mich.--(BUSINESS WIRE)--#diabetes--Hygieia, a digital therapeutics company for insulin therapy, is extending its Series B funding round to $22 million with a lead investment from Firstime ...